Trial Profile
A prospective, observational and longitudinal study to evaluate the efficacy and safety of combination therapy of testosterone undecanoate (Nebido, Bayer Pharma) and vardenafil (Levitra, Bayer Pharma) in patients with hypogonadal erectile dysfunction
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Dec 2015
Price :
$35
*
At a glance
- Drugs Testosterone undecanoate (Primary) ; Vardenafil (Primary)
- Indications Erectile dysfunction; Hypogonadism
- Focus Adverse reactions; Therapeutic Use
- 14 Dec 2015 New trial record